All In MedTech

Device Trial Radar · NCT04953949

IEIK13 For Neurosurgery

First-in-Human Trial of the Safety and Performance of NU-MAX® (IEIK13) as a Hemostatic Agent in Intracranial Neurosurgery

Last checked: Nov 20, 2026Latest source record: Nov 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

80

Actual

Start

Aug 6, 2021

Primary completion

Aug 4, 2023

Study completion Nov 4, 2023

Sponsor

Lead sponsor
3-D Matrix Europe SASNot on our public-company list
Sponsor type
Industry
First posted
Jul 8, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this clinical investigation is to determine the performance and safety profile of NU-MAX® when used as a topical hemostat for oozing bleedings encountered during intracranial procedures, in which control of bleeding by conventional hemostatic techniques is either ineffective or impractical.

Conditions

  • Oozing (Hemorrhage) During Intracranial Procedures

Interventions

  • NU-MAX®Device

    Topical Hemostat

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. % of bleedings reaching hemostasis within 3 minutesTime frame: Intraoperatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Antwerp University Hospital (UZA)

    Edegem, Belgium

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.